[LGD1069: an antagonist to the X retinoid receptor]

Bull Cancer. 2000 Mar;87(3):235-8.
[Article in French]
No abstract available

MeSH terms

  • Animals
  • Anticarcinogenic Agents / chemistry
  • Anticarcinogenic Agents / pharmacology*
  • Bexarotene
  • Cells, Cultured
  • Clinical Trials as Topic
  • Dimerization
  • Drug Eruptions / etiology
  • Drug Evaluation
  • Drug Screening Assays, Antitumor
  • Humans
  • Lung Neoplasms / drug therapy
  • Lymphoma, T-Cell / drug therapy
  • Mice
  • Rats
  • Receptors, Retinoic Acid / antagonists & inhibitors*
  • Retinoid X Receptors
  • Skin Neoplasms / drug therapy
  • Structure-Activity Relationship
  • Tetrahydronaphthalenes / chemistry
  • Tetrahydronaphthalenes / pharmacology*
  • Transcription Factors / antagonists & inhibitors*
  • Transcriptional Activation

Substances

  • Anticarcinogenic Agents
  • Receptors, Retinoic Acid
  • Retinoid X Receptors
  • Tetrahydronaphthalenes
  • Transcription Factors
  • Bexarotene